Smoke-Free Products Drive Philip Morris to Exceed Q4 Forecasts
Philip Morris International (PMI) reported impressive fourth-quarter results, surpassing market expectations thanks to robust sales of smoke-free products like vapes and nicotine pouches. The tobacco giant posted a 7.3% year-on-year revenue increase, reaching $9.71 billion for the quarter ending December 31, 2024. This figure comfortably exceeded the consensus forecast of $9.44 billion.
Smoke-free products, including heated tobacco units and oral nicotine pouches, saw a 9.2% revenue jump to $3.9 billion. Quarterly shipments of these products grew by 5.1% and 22%, respectively, surpassing 40 billion units for the first time. Meanwhile, combustible products, such as traditional cigarettes, also performed well, with revenues rising 6.0% to $5.8 billion and cigarette volumes increasing 1.1% to 152.8 billion units.
Adjusted earnings per share (EPS) for the quarter stood at $1.55, a 14% increase from the previous year and higher than the $1.50 analysts had predicted.
CEO Optimistic About Future Growth
PMI’s CEO, Jacek Olczak, expressed confidence in the company’s future, citing strong momentum across all product categories. “Our smoke-free transformation and unparalleled brand portfolio will continue to deliver excellent performance and create value for our shareholders in 2025 and beyond,” he said.
Olczak also highlighted the recent FDA authorization of PMI’s ZYN nicotine pouches for sale in the U.S. in January 2024. “We hope other pending FDA applications will be accelerated and that more countries adopt effective tobacco harm reduction measures,” he added.
For 2025, PMI forecasts adjusted EPS in the range of $7.04 to $7.17, up from $6.57 in 2024 and ahead of the current consensus estimate of $7.03. The company also expects net revenues to grow by 6-8%.
Key Financial Highlights for Q4 2024
- Revenue: $9.71 billion vs. analyst estimates of $9.44 billion (7.3% year-on-year growth, 2.8% beat)
- Unit Sales of Nicotine Pouches: 46% year-on-year increase
- Adjusted EPS: $1.55 vs. analyst estimates of $1.50 (3.4% beat)
- Adjusted EPS Guidance for 2025: $7.11 at the midpoint, beating analyst estimates by 1.5%
- Operating Margin: 33.6%, up from 31.9% in the same quarter last year
- Sales Volumes: 2.3% year-on-year increase
- Market Capitalization: $203.7 billion
Company Overview
Founded in 1847, Philip Morris International (NYSE: PM) is a global leader in manufacturing and selling tobacco and nicotine-containing products. Its portfolio includes traditional cigarettes, heated tobacco products like IQOS, and oral nicotine pouches such as ZYN.
The company operates in a highly competitive industry where brand strength, marketing strategies, and shifting consumer preferences play a critical role. PMI has successfully adapted to changing trends, such as the rise of vaping and nicotine pouches, while maintaining a strong presence in traditional tobacco products.
Sales Growth and Market Position
Over the past 12 months, PMI generated $37.88 billion in revenue, solidifying its position as one of the most recognized consumer staples companies globally. Its scale provides significant negotiating leverage with distributors, allowing it to strategically place its products in key markets. However, this scale also presents challenges, as the company must continuously innovate to find new growth opportunities.
PMI’s sales have grown at a compounded annual growth rate (CAGR) of 6.4% over the last three years. While this growth rate is modest, the company has consistently increased its product volumes. In Q4 2024, PMI achieved a 7.3% year-on-year revenue growth, outperforming Wall Street’s expectations by 2.8%.
Looking ahead, analysts project a 4.5% revenue growth over the next 12 months, indicating potential demand challenges. However, PMI’s strong financial health and focus on innovation position it well to navigate these challenges.
Cash Flow and Profitability
PMI’s cash profitability remains a standout feature, driven by its lucrative business model. The company’s free cash flow margin averaged 23.6% over the last two years, placing it among the top performers in the consumer staples sector. This strong cash flow enables PMI to reinvest in its business, return capital to shareholders, and maintain a competitive edge.
Key Takeaways from Q4 Results
PMI’s Q4 performance was marked by several positive highlights:
- Smoke-Free Division Growth: Revenue from smoke-free products grew by 9%, driven by a 46% increase in unit sales of nicotine pouches like ZYN.
- Improved Margins: Gross margin and operating margin both expanded, reflecting efficient cost management.
- Strong EPS Performance: Adjusted EPS of $1.55 exceeded analyst expectations, and the company’s 2025 EPS guidance is also above consensus estimates.
Following the earnings release, PMI’s stock rose 7.7% to $141.10, reflecting investor confidence in the company’s growth trajectory.
- South Korea Escalates Tobacco Warnings with Blunt, Fatalistic Labels - June 22, 2026
- Magnolia Commissioner Proposes Ordinance to Ban Vape Shops - June 22, 2026
- Belarus Moves to Ban Vape and E-Cigarette Advertising Under New Bill - June 22, 2026
Related posts:
German Customs Notifies Electronic Cigarettes Should Be Taxed
Are Candy Cigarettes Legal in the United States?
Disposable Vape Myths Debunked: Separating Fact from Fiction
Electronic Cigarettes Worth 6 Billion Tenge Seized in Kazakhstan
Louisiana Vape Directory Published – Elf Bar Not Included
Vietnam’s Minister Nguyen Hong Dien: No Testing of E-Cigarettes
